0
2020
Meningococcal Vaccine Market

Meningococcal Vaccine Market

by Serogroup (MenACWY, MenB/BC, MenC, MenAC, and MenA), Vaccine Type (Conjugate, Polysaccharide, and Subcapsular), and End User (Pediatric, Adults, and Travelers): Global Opportunity Analysis and Industry Forecast, 2018-2026

Report Code: A00240
Pages: 197
Apr 2020 | 16072 Views
Author(s) : Sahil , Apoorva
Tables: 105
Charts: 28
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Meningococcal Vaccine Market

Request Now !

The global meningococcal vaccine market size was valued at $1,935.5 million in 2018, and is projected to reach $4,192.6 million by 2026, registering a CAGR of 9.5% from 2019 to 2026. Invasive meningococcal disease (IMD) is a bacterial infection caused by a gram-negative coccus, Neisseria meningitidis, which includes spectrum of infections including meningitis, bacteremia (meningococcemia), and bacteremia pneumonia. Although meningococcal disease is rare but is associated with high fatality of up to 50% if left untreated and often results in serious complications there  after. Meningococcal meningitis results in infection of the lining of the brain and spinal cord and also has a potential to cause large epidemics as well as endemics. The disease is generally transmitted through direct contact with droplets of respiratory or throat secretions from patients or asymptomatic carriers. Various serotypes of N. meningitidis are included in 12 serogroups of which only 5 serogroups including A, B, C, W, and Y are responsible for the majority of disease worldwide. However, circulation of these serogroups is highly unpredictable and varies over time across age groups and geographies. Vaccines for each of these serogroups are available in the market. 

The global meningococcal vaccine market is expected to experience significant market growth during the forecast period as there has been an increase in adoption in several countries across the globe in their national immunization programs. In addition, surge in meningococcal outbreaks in several countries has led to upsurge in demand for meningococcal vaccines, which further facilitate the growth of the market. However, stringent government regulations for the approval of new vaccines and recall of several products due to contamination are expected to impede the market growth. On the contrary, increase in R&D for meningococcal vaccines and global increase in healthcare spending provide significant growth opportunities for the meningococcal vaccine market. 

Meningococcal-Market-2019-2026

Global Meningococcal Vaccine Market Segmentation

The Meningococcal Vaccine Market is segmented on the basis of serogroup, vaccine type, end user, and region. The serogroups covered in the study include MenACWY, MenB/BC, MenC, MenAC, and MenA. Depending on vaccine type, the market is classified into conjugate, polysaccharide, and subcapsular. According to end user, the market is segmented into pediatric, adults, and travelers .Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Meningococcal Vaccine Market
By Vaccine Serotype

Your browser does not support the canvas element.

MenACWY vaccines segment holds a dominant position in 2019 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Vaccine serotype segment review

By vaccine serotype, the MenACWY vaccine and MenC vaccine segments collectively accounted for around 74.3% market share in 2018, with the former constituting around 46.2% share, and are expected to experience rapid growth during the forecast period as these vaccines exhibit increase in adoption in several countries across the globe in their national immunization programs. Moreover, meningococcal out breaks in several countries has led to upsurge in demand for meningococcal vaccines, which further swelled up the growth of the market is another reason that boosts the growth of the meningococcal vaccine market. However, MenA vaccine is anticipated to be the fastest growing segment and is estimated to garner significant share by 2026, registering a CAGR of 13.5%.

Meningococcal Vaccine Market
By Vaccine Type

Your browser does not support the canvas element.

Conjugate segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Vaccine type segment review

By vaccine type, the conjugate vaccine segment accounted for the major market share in 2018, and is expected to experience rapid growth during the forecast period, owing to its key advantages such as longer lasting immunity and its ability to induce herd immunity. Moreover, various key players have several meningococcal conjugate vaccine products in their pipeline that provides significant opportunities for the growth of the conjugate vaccine market. In addition, conjugate vaccine is anticipated to be the fastest growing segment and is estimated to register a CAGR of 10.2%.

Meningococcal Vaccine Market
By End User

Your browser does not support the canvas element.

Pediatric segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

End user segment review

By end user, the pediatric and adult segments collectively accounted for around 95.2% market share in 2018, with the former constituting around 62.35% share and are expected to experience rapid growth during the forecast period due to increase in adoption in several countries across the globe in their national immunization programs. In addition, the pediatric segment is anticipated to be the fastest growing, registering a CAGR of 10.0%.

North America and Europe are the most lucrative markets due to increase in awareness for meningococcal diseases, ease of product availability, and surge in outbreaks for meningococcal diseases. The North America for largest market share for meningococcal vaccine market revenue in 2018. In addition, it is estimated to garner significant share by 2026 at an estimated CAGR of 9.4%. The Asia-Pacific Meningococcal Vaccine Market is estimated to account for the fastest growing sub-segment globally. The steady meningococcal vaccine market growth in this region can be primarily attributed to the presence of large population, improving access to healthcare systems, and increase in awareness for meningococcal diseases.

Meningococcal Vaccine Market
By Region

2026
North America 
Europe
Asia-Pacific
LAMEA

Asia-Pacific region would exhibit the highest CAGR of 14.7% during 2019-2026.

Get more information on this report : Request Sample Pages

Comprehensive competitive analysis and profiles of major meningococcal vaccine market players such as Bio-Manguinhos, Bio-Med Pvt. Limited, Chongqing Zhifei Biological Products Co., Ltd., GlaxoSmithKline Plc, Hualan Biological Engineering Inc., Incepta Pharmaceuticals Ltd., Pfizer Inc., Sanofi S.A., Serum Institute of India Pvt. Ltd, and Walvax Biotechnology Co., Ltd. are provided in this report.

Key Benefits For Stakeholders

  • The meningococcal vaccine market share and analysis is based on a comprehensive analysis of key developments in the industry.

  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the global market.

  • The study provides an in-depth analysis of the meningococcal vaccine market trends to elucidate the imminent investment pockets.

  • The global meningococcal vaccine market trends are studied from 2018 to 2026.

  • Information about key drivers, restrains, and opportunities and their impact analysis on the meningococcal vaccine market size is provided.

  • Porter’s five forces analysis illustrates the potency of buyers and suppliers operating in the industry.

  • The quantitative analysis of the global meningococcal vaccine market from 2019 to 2026 is provided to determine the market potential.

Meningococcal Vaccine Market Report Highlights

Aspects Details
By VACCINE SEROTYPE
  • MenACWY
  • MenB & Manic
  • MenC
  • MenA
  • MenAC
By VACCINE TYPE
  • Conjugate
  • Polysaccharide
  • Subcapsular
By END USER
  • Pediatric
  • Adult
  • Travelers
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (UK, Germany, France, the Netherlands, Spain, Rest of Europe)
  • Asia Pacific  (China, Australia, Rest of Asia-Pacific)
  • LAMEA  (Latin America, Middle-East, Africa)
Key Market Players Chongqing Zhifei Biological Products Co., Ltd., GlaxoSmithKline Plc, Bio-Med Pvt. Limited, Walvax Biotechnology Co., Ltd., PFIZER INC., Hualan Biological Engineering Inc., Incepta Pharmaceuticals Ltd., SERUM INSTITUTE OF INDIA PVT. LTD, SANOFI S.A., Bio-Manguinhos
 

Loading Table Of Content...


 
 

Meningococcal infection is quite rare but is associated with high fatality of up to 50% if left untreated and often results in serious complications thereafter. In addition, meningococcal meningitis is also has a potential to cause large epidemics as well as endemics. There by, immunization through meningococcal vaccines is the best available defense against the disease. 

Meningococcal vaccines are expected to witness high adoption in the near future, owing to increase in number of immunization programs across the globe. In addition, the market is exhibiting high growth rate, owing to surge in awareness about use of the meningococcal vaccines. North America holds the largest share for meningococcal vaccines market. Moreover, North America and Europe are expected to offer lucrative growth opportunities to the key players. This is majorly attributed to factors such as improvement in healthcare facilities, rise in disposable income, and rapid improvement in economic conditions. However, Asia-Pacific is expected to grow at the highest rate. Meningococcal vaccine manufacturers and distributors have focused on expanding their presence in the emerging economies to strengthen their foothold in the market.
 

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The total market value of Meningococcal market is $1935.55 million in 2018.

A. The forcast period for Meningococcal market is 2019 to 2026

A. The market value of Meningococcal market in 2020 is $2508.54 million.

A. The base year is 2018 in Meningococcal market

A. Top companies such as,GSK, Sanofi, Pfizer, Hualan, Incepta held a high market position in 2019. These key players held a high market postion owing to the strong geographical foothold in different regions.

A. Vaccine serotype segment is the most influencing segment owing to surge in prevalence of meningitis disease across the globe. Hence, this leads to surge in demand for betetr management if symptoms associated with the condition.

A. The major factor that fuels the growth of the global Meningococcal market includes rise in prevalence of lifestyle disorders such as diabetes, obesity, hypertension and others. This leads to surge in demand for Meningococcal devices which contribute to the growth of the market.

A. Asia-Pacific has the highest growth rate in the market which is growing due to the contribution of the following emerging countries such as India with a CAGR of 14.7%. This is due to improvement in health awareness, development in healthcare infrastructure, and rise in number of hospitals & diagnostic centers equipped with advanced medical facilities.

A. contagious infection of the membranes that surround the brain and spinal cord caused by Neisseria meningitides

A. Meningococcal vaccine used to cure the diseases caused by microorganisms such as Neisseria meningitides

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
RELATED TAGS

Purchase Full Report of
Meningococcal Vaccine Market

Start reading instantly.
This Report and over 54,639+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Apr 2021 - Apr 2022)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Apr 2021 - Apr 2022)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Apr 2021 - Apr 2022)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Apr 2021 - Apr 2022)
  • Enterprise
    License/PDF

  • $10,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Apr 2021 - Apr 2022)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers